Mechanism of action of biological disease--modifying antirheumatic drugs
Takahashi, N.; Ishiguro, N.
Nihon Rinsho. Japanese Journal of Clinical Medicine 74(6): 882-886
2016
ISSN/ISBN: 0047-1852 PMID: 27311173 Document Number: 689446
Document emailed within 1 workday
Related Documents
Harth, M. 1992: Mechanisms of action of disease modifying antirheumatic drugs Journal of Rheumatology. Suppl 32: 100-103Mielens, Z.E.; Connolly, K.; Stecher, V.J. 1985: Effect of disease modifying antirheumatic drugs and nonsteroidal antiinflammatory drugs upon cellular and fibronectin responses in a pleurisy model Journal of Rheumatology 12(6): 1083-1087
Capell, H. 2002: Longterm maintenance therapy with disease modifying antirheumatic drugs Journal of Rheumatology. Supplement 66: 38-43
Galindo-Rodriguez, G.; Aviña-Zubieta, J.A.; Russell, A.S.; Suarez-Almazor, M.E. 1999: Disappointing longterm results with disease modifying antirheumatic drugs. A practice based study Journal of Rheumatology 26(11): 2337-2343
Osiri, M.; Akkasilpa, S.; Deesomchok, U. 2000: Initial disease modifying antirheumatic drugs and prednisolone prescriptions for patients with rheumatoid arthritis: a 15-year study Journal of the Medical Association of Thailand 83(3): 217-224
Aletaha, D.; Smolen, J.S. 2002: Effectiveness profiles and dose dependent retention of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. An observational study Journal of Rheumatology 29(8): 1631-1638
Le Loët, X.; Nordström, D.; Rodriguez, M.; Rubbert, A.; Sarzi-Puttini, P.; Wouters, J.M.G.W.; Woolley, J.Michael.; Wright, N.; Lawrence, C.; Appleton, B. 2008: Effect of anakinra on functional status in patients with active rheumatoid arthritis receiving concomitant therapy with traditional disease modifying antirheumatic drugs: evidence from the OMEGA Trial Journal of Rheumatology 35(8): 1538-1544
Müller, P.; Dammann, H.G.; Langer, M.; Leucht, U.; Simon, B. 1989: Ranitidine ameliorates acemetacin and indomethacin-induced changes of the gastroduodenal mucosa, without modifying the pharmacokinetic behavior of both antirheumatic drugs Zeitschrift für Gastroenterologie 27(2): 83-86
Wolfe, F.; Rehman, Q.; Lane, N.E.; Kremer, J. 2001: Starting a disease modifying antirheumatic drug or a biologic agent in rheumatoid arthritis: standards of practice for RA treatment Journal of Rheumatology 28(7): 1704-1711
Kuuliala, A.; Leirisalo-Repo, M.; Möttönen, T.; Hannonen, P.; Nissilä, M.; Kautiainen, H.; Korpela, M.; Julkunen, H.; Hakola, M.; Repo, H. 2005: Serum soluble interleukin-2 receptor predicts early remission in patients with recent-onset rheumatoid arthritis treated with a single disease-modifying antirheumatic drug Clinical and Experimental Rheumatology 23(2): 243-246
Mathies, H. 1989: Immunopathologic and inflammatory processes in chronic polyarthritis. Discussion principles of the mechanisms of action of antirheumatic drugs Fortschritte der Medizin 107(9): 197-200
Imai, S. 1975: Action mechanism of anti-hypertensive drugs, with special reference to beta blocking drugs Nihon Jinzo Gakkai Shi 17(7): 674-677
Bellamy, N.; Anastassiades, T.P.; Buchanan, W.W.; Davis, P.; Lee, P.; McCain, G.A.; Wells, G.A.; Campbell, J. 1991: Rheumatoid arthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials of antirheumatic drugs Journal of Rheumatology 18(12): 1901-1907
Sidorenko, T.V.; Boĭko, A.N.; Davydovskaia, M.F.; Zolotova, S.N.; Lash, N.I.; Popova, N.F.; Khachanova, N.V.; Shur, S.G.; Gusev, E.I. 2009: Adherence to long-term therapy with disease modifying drugs Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 109(7 Suppl 2: 107-113
Scott, I.C.; Kingsley, G.H.; Scott, D.L. 2013: Can we discontinue synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis? Clinical and Experimental Rheumatology 31(4 Suppl 78: S4-S8
Pohjankoski, H.; Latva, K.; Kautiainen, H.; Säilä, H.; Klaukka, T.; Virta, L.; Puolakka, K.; Pohjolainen, T.; Savolainen, A. 2011: First-year purchases of disease-modifying drugs of incident patients with chronic juvenile arthritis in Finland Clinical and Experimental Rheumatology 29(5): 878-881
Kholmogorov, V.E.; Shurygin, A.L. 1981: Mechanism of biological action of UV-irradiated blood Biofizika 26(3): 540-541
Toida, I. 1975: Action mechanism of antitubercular drugs Kekkaku: 50(11): 536-539
Abood, L.G. 1975: Mechanism of action of psychotomimetic drugs Psychopharmacology Bulletin 11(3): 52-53
Luk'ianova, E.M.; Rodionov, V.P. 1977: Mechanism of biological action of the parathyroid gland hormone in rickets Pediatriia 3: 84-86